Cardinal Health’s first quarter results were received negatively by the market, with revenue growth of 11% year over year ...

On May 1, TD Cowen upped its price target on Cardinal Health, Inc. (NYSE:CAH) from $251 to $255, while keeping a ‘Buy’ rating ...

Cardinal Health, a company that had repeatedly come on Mad Money telling a terrific story, just imploded. Did I tell people ...

Cardinal Health raises its fiscal-year adjusted earnings guidance for the second time this year, helping investors look past ...

Cardinal Health is likely to announce a dividend increase in May, continuing its 31-year streak of consecutive dividend growth based on historical trends. Analysts expect a consen ...

Apple ramps $100B buybacks and 4% dividend; May dividend hike forecasts include Cardinal Health (1–3%) plus bigger boosts ...

Cardinal Health’s Other segment saw a 31% increase in revenue in the third quarter of fiscal year 2026 to $1.7 billion, ...

Cardinal Health’s Pharma segment may have been the star of the third quarter fiscal year 2026, but the company’s Other segment, which includes at-Home Solutions, held its own with ...

Shares of Cardinal Health are taking a hit on Thursday after the drug distributor reported mixed quarterly results. We're not ...

We've taken a closer look at Cardinal Health's quarterly results and conference call following Thursday's sell-off. Our ...

Pharma segment growth was driven by strong demand across specialty, generics, and consumer health, despite revenue headwinds ...